Mode
Text Size
Log in / Sign up
Phase 3 Completed N=170 Randomized Treatment

Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma

Source: ClinicalTrials.gov NCT00002766 ↗
Enrolled (actual)
170
Serious AEs
42.4%
Results posted
Feb 2016
Primary outcomePrimary: Complete Remission (CR) — 50; 50; 14; 11 participants

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which regimen of combination chemotherapy is more effective for acute lymphoblastic leukemia, lymphoblastic lymphoma, or chronic myelogenous leukemia. PURPOSE: This randomized phase III trial is studying two different chemotherapy regimens and comparing them to see how well they work in treating adults with acute lymphoblastic leukemia, lymphoblastic lymphoma, or chronic myelogenous leukemia.

Outcome Measures

OutcomeResultp-value
PRIMARY
Complete Remission (CR)
50; 50; 14; 11; 5; 14

Eligibility Criteria

DISEASE CHARACTERISTICS:

  • Diagnosis of one of the following malignancies:
  • Acute lymphoblastic leukemia (ALL) of B- or T-cell lineage
  • Philadelphia chromosome-positive ALL eligible
  • Lymphoblastic lymphoma
  • Chronic myelogenous leukemia in lymphoid blast crisis

PATIENT CHARACTERISTICS:

Age:

  • 18 and over

Performance status:

  • Karnofsky 20-100%

Life expectancy:

  • Not specified

Hematopoietic:

  • Not specified

Hepatic:

  • Bilirubin no greater than 2.0 mg/dL
  • Glucocorticoids for higher bilirubin allowed prior to entry, at principal investigator's discretion

Renal:

  • Creatinine no greater than 2.0 mg/dL
  • Glucocorticoids or renal radiotherapy for higher creatinine allowed prior to entry, at principal investigator's discretion

Cardiovascular:

  • Left ventricular ejection fraction at least 50%

Other:

  • Not pregnant

PRIOR CONCURRENT THERAPY:

Biologic therapy

  • No prior biologic therapy

Chemotherapy

  • No prior chemotherapy

Endocrine therapy

  • No prior endocrine therapy

Radiotherapy

  • No prior radiotherapy

Surgery

  • No prior surgery
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00002766). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search